Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukán®in adjuvant arthritis

Toxicology and Industrial Health

Volumn 25, Issue 5, 2009, Pages 329-335

  Bauerova K ^a   Paulovicova E ^b   Mihalova D ^a   Svik K ^c   Ponist S ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

adjuvant arthritis; Candida utilis; glucomannan; immunomodulators; Imunogluk n ; Pleurotus ostreatus; rheumatoid arthritis

Indexed keywords

FREUND ADJUVANT; GAMMA GLUTAMYLTRANSFERASE; IMMUNOMODULATING AGENT; IMUNOGLUKAN; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; MANNAN; MONOCYTE CHEMOTACTIC PROTEIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME ACTIVITY; FLOW CYTOMETRY; HINDLIMB; HOMOGENATE; MALE; MYCOBACTERIUM BUTYRICUM; NONHUMAN; RAT; SPECTROPHOTOMETRY; TREATMENT DURATION;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CANDIDA; GLUCANS; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-1ALPHA; INTERLEUKIN-4; MALE; MANNANS; PLEUROTUS; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; HUMAN PAPILLOMAVIRUS; MYCOBACTERIUM BUTYRICUM; PICHIA JADINII; PLEUROTUS OSTREATUS; RATTUS;

EID: 68849098402     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233709102945     Document Type: Article

References (33)

1. Adams DS, Pero SC, Petro JB, Nathans R, Mackin WM, Wakshull E (1997) PGG-Glucan activates NF-kappaB-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J Leukoc Biol 62: 865–873.
2. Bauerová K, Bezek S (1999) Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys 8: 5–20.
3. Bauerová K, Ponist S, Ondrejicková O, Komendová D, Mihalová D (2006) Association between tissue gamma-glutamyl transferase and clinical markers of adjuvant arthritis model in Lewis rats. Neuro Endocrinol Lett 27: 172–175.
4. Battle J, Ha T, Li C, Della Beffa V, Rice P, Kalbfleisch J, Browder W, Williams D (1998) Ligand binding to the 1−3-beta-d-glucan receptor stimulates NF-kappaB activation, but not apoptosis in U937 cells. Biochem Biophys Res Commun 249: 499–504.
5. Bobek P, Galbavy S (2001) Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci 58: 164–168.
6. Bobek P, Nosálová V, Cerná S (2001) Effect of pleuran (beta-glucan from Pleurotus ostreatus) in diet or drinking fluid on colitis in rats. Nahrung 45: 360–363.
7. Brown RK, Kelly FJ (1996) Peroxides and other products. In: NA Punchard, FJ Kelly (eds), Free Radicals, a Practical Approach. Oxford: Oxford University Press, pp. 119–131.
8. Brown GD, Gordon S, Dunn W (2001) Immune recognition. A new receptor for beta-glucans. Nature 423: 36–37.
9. Cross GG, Jennings HJ, Whitfield DM, Penney CL, Zacharie B, Gagnon L (2001) Immunostimulant oxidized beta-glucan conjugates. Int Immunopharmacol 1: 539–550.
10. Czop JK (1986) The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. Pathol Immunopathol Res 5: 286–296.
11. Chorvatovicová D, Machová E, Sandula J, Kogan G (1999) Protective effect of the yeast glucomannan against cyclophosphamide –induced mutagenicity. Mutat Res 444: 117–122.
12. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997) Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 94: 10895–10900.
13. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356–361.
14. Kogan G, Pavliak V, Masler L (1988) Structural studies of mannans from the cell walls of the pathogenic yeasts Candida albicans serotypes A and B Candida parapsilosis. Carbohydr Res 172: 243–253.
15. Kogan G, Sandula J, Simkovicova V (1993) Glucomannan from Candida utilis. Folia Microbiol 38: 219–224.
16. Kogan G, Staško A, Bauerová K, Polovka M, Šoltés L, Brezová V, Navarová J, Mihalová D (2005) Antioxidant properties of yeast (1→3)-β-d-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis. Carbohydr Polym 61: 18–28.
17. Majtán J, Kogan G, Kovácová E, Bíliková K, Simúth J (2005) Stimulation of TNF-α release by fungal cell wall polysaccharides. Z Naturforsch 60: 921–926.
18. Miadoková E, Svidová S, Vlcková V, Dúhová V, Nad'ová S, Rauko P, Kogan G (2006) Diverse biomodulatory effects of glucomannnan from Candida utilis. Toxicology in vitro 20: 649–657.
19. Mihalová D, Poništ S, Kucharská J, Komendová D, Bauerová K (2007) Total antioxidant status – systemic marker of oxidative stress in adjuvant arthritis. Chemicke Listy 101: 225–226.
20. Nosál'ová V, Bobek P, Cerná S, Galbavý S, Stvrtina S (2001) Effects of pleuran (beta-glucan isolated from Pleurotus ostreatus) on experimental colitis in rats. Physiol Res 50: 575–581.
21. Ondrejickova O, Ziegelhoeffer A, Gabauer I, Sotnikova R, Styk J, Gibala P, Sedlak J, Horakova L (1993) Evaluation of ischemia-reperfusion injury by malondialdehyde, glutathione and gamma-glutamyl transpeptidase: lack of specific local effects in diverse parts of the dog heart following acute coronary occlusion. Cardioscience 4: 225–230.
22. Orlowski M, Meister A (1970) The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A 67: 1248–1255.
23. Prokopová A, Kéry V, Stanciková M, Grimová J, Capek P, Sandula J, Orviský E (1993) Methyl-α-d-mannopyranoside, mannooligosaccharides and yeast mannans inhibit development of rat adjuvant arthritis. J Rheumatology 20: 673–677.
24. Rice PJ, Kelley JL, Kogan G, Ensley HE, Kalbfleisch JH, Browder IW, Williams DL (2002) Human monocyte scavenger receptors are pattern recognition receptors for (1, 3)-beta-d-glucans. J Leukoc Biol 72: 140–146.
25. Rice-Evans C, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234: 279–293.
26. Sakurai T, Ohno N, Yadomae T (1992) Intravenously administered(1→3)-beta-d-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 augments murine peritoneal macrophage functions in vivo. Chem Pharm Bull (Tokyo) 40: 2120–2124.
27. Sakurai T, Ohno N, Yadomae T (1996) Effects of fungal beta-glucan and interferon-gama on the secretory functions of murine alveolar macrophages. J Leukoc Biol 60: 118–124.
28. Schepetkin IA, Quinn MT (2006) Botanical polysaccharides: macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 6: 317–333.
29. Tzianabos AO (2000) Polysaccharide immunomodulators as therapeutic agents: structural aspects and biological function. Clin Microbiol Rev 13: 523–533.
30. Vannier E, Miller MC, Dinarello CA (1992) Coordinated anti-inflammatory effects of interleukin 4: interleukin 4 suppresses interleukon1 production but up regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A 89: 4076–4080.
31. Vlcková V, Dúhova V, Svidová S, Farkassová A, Kamasová S, Vlcek D, Kogan G, Rauko P, Miadoková E (2004) Antigenotoxic potential of glucomannan on four model test systems. Cell Biol Toxicol 20: 325–332.
32. Waage A, Brandtzaeg P, Espevik T, Halstensen A (1991) Current understanding of the pathogenesis of gram-negative shock. Infect Dis Clin North Am 5: 781–791.
33. Wakshull E, Brunke-Reese D, Lindermuth J, Fisette L, Nathans RS, Crowley JJ, Tufts JC, Zimmerman J, Mackin W, Adams DS (1999) PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. Immunopharmacology 41: 89–107.